In Sequence: a genomics podcast by Genuity Science

By: In Sequence: a genomics podcast by Genuity Science
Listen for free

  • Summary

  • Terms such as ‘precision health’, ‘genomics’, and ‘bioinformatics’ have become popular in recent years. We hear them used more and more by experts talking about scientific research in the context of medicine and future health. But what is the significance of these terms when it comes to difficult-to-treat diseases such as cancer, diabetes, multiple sclerosis and other complex or rare diseases? How is genomics going to impact us as patients, families, and health care providers? The study of our genes (genomics) is helping scientists and clinical researchers gain a better understanding of health and disease. This deeper knowledge may identify the causes of such diseases and the risks associated with them, as well as shed some light on how diseases progress and respond to different treatments. Imagine if we could develop more precise treatments with minimal side-effects or even prevent these diseases from developing in the first place! This is not a podcast for geneticists or genomic scientists – they are already wildly excited about this stuff. This is for the rest of us who want to be educated on what genomics is and how it is revolutionising future health for all of us.
    All rights reserved
    Show More Show Less
Science
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
activate_samplebutton_t1
Episodes
  • NASH: unravelling the complexity of liver disease with genomics.

    NASH: unravelling the complexity of liver disease with genomics.
    Apr 28 2021
    In episode 8, we talk to Dr. Scott Friedman, internationally renowned physician and scientist, who explains why Non-alcoholic steatohepatitis or NASH is a liver disease that is becoming a growing health concern world-wide. Dr. Friedman describes the extraordinary capacity for the liver to regenerate, his ground-breaking research into the cause of inflammation and resulting scarring or fibrosis of the liver, and how Whole Genome Sequencing is being used to improve our understanding of why some people have a higher risk of developing the condition than others. Finally, he talks about how drug companies are leveraging all of this growing information in order to develop better diagnostics and new effective treatments for NASH and other forms of chronic liver disease.
    Show More Show Less
    41 mins
  • Ep 7: In A Heartbeat - How Whole Genome Sequencing is telling us more about Heart Failure

    Ep 7: In A Heartbeat - How Whole Genome Sequencing is telling us more about Heart Failure
    Mar 31 2021
    Professor Mark Ledwidge, Co-Founder and Director of the Heartbeat Trust talks about his research and how Whole Genome Sequencing is helping to unravel some of the mysteries surrounding heart failure. He discusses the challenges around the sub-type of heart failure known as Heart Failure with Preserved Ejection Fraction where the pump itself is working correctly but the heart is unable to fill adequately to provide enough blood for the body’s needs. We also hear from Mark’s father, Tom Ledwidge who, at 81 leads a very healthy and active life despite his own heart issues. Tom advocates strongly for clinical research and is a research participant himself.
    Show More Show Less
    52 mins
  • Ep 6: Chasing a Cure: Searching for answers to Congenital Hyperinsulinism leveraging genomics

    Ep 6: Chasing a Cure: Searching for answers to Congenital Hyperinsulinism leveraging genomics
    Feb 26 2021
    In celebration of Rare Disease Day, we hear from a panel of five inspiring guests - all who share their unique perspectives about one particular rare condition called Congenital Hyperinsulinism. Join us to hear these valuable insights from Julie Raskin – Co-Founder and Executive Director, Congenital Hyperinsulinism International (CHI), New Jersey, and mom to Ben who has congenital hyperinsulinism; Sheila Bose – Vice President of the Board of Directors for CHI and parent to 3 children born with congenital hyperinsulinism; Dr Sarah Flanagan - Associate Professor in Genomic Medicine at the University of Exeter Medical School; Dr. Diva De León-Crutchlow - Chief of Endocrinology and Diabetes and Director of the Congenital Hyperinsulinism Center at Children's Hospital of Philadelphia; and Dr. Paul Thornton – Medical Director of the Endocrine and Diabetes Program at Cook Children’s Medical Center, Texas.
    Show More Show Less
    32 mins

What listeners say about In Sequence: a genomics podcast by Genuity Science

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available